Sermorelin
Sermorelin Acetate
The clinically established GHRH analogue with the longest safety record in anti-aging medicine.
Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptides discussed may be research compounds not approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. Read our full disclaimer →
Quick Reference
| Peptide Class | Growth Hormone Releasing Hormone (GHRH) Analogue |
| Half-Life | ~10–20 minutes |
| Administration | Subcutaneous injection |
| Typical Dosage | 200–300 mcg before bed |
| Cycle Length | 3–6 months (longer cycles than GHRPs) |
| Evidence Level | Strong Human Clinical |
| Legal Status | FDA-approved (Geref) — available via prescription through licensed telehealth providers |
| Approximate Cost | $150–$400/month via telehealth |
How Sermorelin Works
Binds to GHRH receptors on pituitary somatotrophs, stimulating natural pulsatile GH release that mirrors youthful physiology.
Sermorelin is a 29-amino acid analogue of endogenous GHRH that stimulates the pituitary gland to produce and secrete growth hormone in a natural, pulsatile pattern. Unlike synthetic GH injections, Sermorelin works through the body's own regulatory feedback mechanisms — the pituitary retains control over GH output, preventing the supraphysiological levels associated with exogenous GH. This natural regulation is why Sermorelin has a superior long-term safety profile compared to direct GH therapy.
Evidence Base
Preclinical Evidence
Extensive preclinical data supporting GH stimulation, improvements in body composition, and sleep architecture enhancement.
Human Evidence
Sermorelin has the most robust clinical evidence base of any GH secretagogue. Multiple randomized controlled trials demonstrate improvements in sleep quality, body composition, bone density, and quality-of-life measures in GH-deficient adults. It was FDA-approved under the name Geref for pediatric GH deficiency.
Anecdotal Evidence
Widely used in anti-aging medicine and functional medicine practices. Patients report gradual but sustained improvements in sleep depth, energy levels, body composition, and skin quality over 3–6 month protocols. The effects are described as more subtle but more durable than synthetic GH.
Key PubMed References:
Safety Profile
Side Effects
Mild injection-site reactions, flushing, and headache are the most common. Rarely, water retention or joint discomfort. The natural regulatory mechanism prevents the side effects associated with exogenous GH (carpal tunnel, acromegaly).
Contraindications
Active malignancy, pregnancy. Requires prescription and physician monitoring due to FDA-regulated status.
PeptidePilot Assessment
Sermorelin is PeptidePilot's top recommendation for users who want clinically supervised GH optimization with the strongest safety record. In our algorithm, it scores highest for users aged 40+ who prioritize longevity, sleep quality, and sustainable anti-aging protocols over rapid body composition changes. Because it requires a prescription, we route Sermorelin-matched users to our telehealth partners (Hone Health, Defy Medical) rather than research peptide vendors.
📊 16% of PeptidePilot users in the anti-aging and longevity category receive Sermorelin as their top match
Frequently Asked Questions
Explore More Peptides
The most researched healing peptide for joints, tendons, and gut tissue.
Systemic tissue repair and anti-inflammatory recovery for athletes and injury rehabilitation.
The cleanest growth hormone secretagogue for muscle growth, fat loss, and sleep quality.
Extended-release GHRH analogue that amplifies and sustains growth hormone pulses.
The most clinically validated peptide for weight loss and metabolic health.
The next-generation dual-agonist delivering superior weight loss to Semaglutide in clinical trials.